Factor V Leiden and thrombin generation and risk of recurrent thrombotic episodes in a patient cohort with venous thromboembolism. The list study

被引:0
|
作者
Chaireti, R. [1 ]
Jennersjo, C. [1 ]
Lindahl, T. L. [2 ]
机构
[1] Univ Linkoping, Emergenecy Med, Linkoping, Sweden
[2] Univ Linkoping, Clin & Expt Med, Linkoping, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP-WE-334
引用
收藏
页码:738 / 738
页数:1
相关论文
共 50 条
  • [1] Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
    Chaireti, Roza
    Jennersjo, Cecilia
    Lindahl, Tomas L.
    THROMBOSIS RESEARCH, 2009, 124 (02) : 178 - 184
  • [2] Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.
    Ridker, P
    Miletich, J
    Stampfer, M
    Goldhaber, S
    Hennekens, C
    BLOOD, 1995, 86 (10) : 2448 - 2448
  • [3] Factor V Leiden and recurrent venous thromboembolism
    Ridker, PM
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (05) : 815 - 816
  • [4] The risk of recurrent venous thromboembolism in patients with factor V Leiden mutation
    Simioni, P
    Prandoni, P
    Lensing, AWA
    Scudeller, A
    Sardella, C
    Prins, MR
    Villalta, S
    Dazzi, F
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : OC747 - OC747
  • [5] The risk of recurrent venous thromboembolism in patients with and without factor V Leiden
    Eichinger, S
    Pabinger, I
    Stumpflen, A
    Hirschl, M
    Bialonczyk, C
    Schneider, B
    Mannhalter, C
    Minar, E
    Lechner, K
    Kyrle, PA
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (04) : 624 - 628
  • [6] The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism
    Eichinger, S
    Weltermann, A
    Mannhalter, C
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Schönauer, V
    Lechner, K
    Kyrle, PA
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (20) : 2357 - 2360
  • [7] Endogenous thrombin potential (ETP) for assessing the risk of recurrent venous thromboembolism.
    Eichinger, S
    Hron, G
    Weltermann, A
    Kollars, M
    Kyrle, PA
    BLOOD, 2005, 106 (11) : 464A - 464A
  • [8] The risk for recurrent venous thromboembolism in carriers of factor V Leiden and prothrombin mutation
    Tormene, D.
    Carraro, S.
    Ferri, V
    Simioni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 875 - 875
  • [9] Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden
    Lincz, Lisa F.
    Lonergan, Amy
    Scorgie, Fiona E.
    Rowlings, Phillip
    Gibson, Richard
    Lawrie, Andrew
    Seldon, Michael
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2006, 35 (06) : 435 - 439
  • [10] Simultaneous presence of prothrombin 20210A and factor V Leiden does not increase risk of venous thromboembolism.
    Hrachovinová, I
    Vorlová, Z
    BLOOD, 1998, 92 (10) : 120B - 120B